Advertisement
Clinical Trials
Subscribe to Clinical Trials
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Researchers Test Device to Help Deaf Children Detect Sounds

February 13, 2015 4:48 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

The device goes beyond cochlear implants that have brought hearing to many deaf children but that don't work for tots who lack their hearing nerve. Read more...                 

Closing the Knowledge Gap on Cancer Drug Toxicity

February 12, 2015 3:59 pm | by David Jackson, Ph.D., Chief Innovation Officer, MolecularHealth | Articles | Comments

There is a dangerous knowledge gap in the use of cancer medications that needs to be closed, immediately. Read more...                                                          

Science is Afire With Plans to Help Smokers Quit

February 12, 2015 12:25 pm | by Cynthia Fox, Science Editor | Articles | Comments

All types of scientists are at work, on all kinds of quit-smoking aids, from an anti-smoking vaccine to a biomarker test. Read more...                                         

Advertisement

Europe's First Fully Remote Diabetes Trial Approved

February 11, 2015 9:46 am | News | Comments

This remote clinical study to include full electronic informed consent. Read more...                            

CDK4/6 Inhibitor: Promising Results for Treating Breast Cancer

February 9, 2015 1:06 pm | by Drug Discovery & Development staff | Articles | Comments

The words “exciting,” “breakthrough,” and “standard-of-care-changing” are being used with regard to cyclin-dependent kinase (CDK) 4 and 6 inhibitors and metastatic breast cancer. Read more...                                       

A Look at Some Vaccine-Related Legislation in Several States

February 6, 2015 4:07 pm | by Associated Press | News | Comments

Several state legislatures are debating vaccine-related measures as dozens of people have fallen ill from a measles outbreak that started at Disneyland in December and spread beyond the theme park. Here is a look at some of the legislation around the country. Read more...

The Longevity of Attention Deficit Drugs

February 5, 2015 5:09 pm | by Stephanie Guzowski, Editor | Articles | Comments

Can A.D.H.D. drugs help “normalize“ a child’s brain? Recent research suggests that A.D.H.D. medication may regulate the brain over time, rewiring neural connections, so that the focus and in-control effect endures. Read more...

Needle Biopsies May Be Safe in Pancreatic Cancer

January 29, 2015 4:06 pm | by Cynthia Fox, Science Editor | Articles | Comments

Oncologists and patients who fear tumor needle biopsies—thinking they may cause tumor bits to break off and “seed” cancer elsewhere—may rest easier after reassuring Mayo Clinic news. Read more...                   

Advertisement

New Biological Evidence Reveals Link Between Brain Inflammation, Depression

January 29, 2015 10:46 am | by Centre for Addiction and Mental Health | News | Comments

A new study by the Centre for Addiction and Mental Health (CAMH) found that the measure of brain inflammation in people who were experiencing clinical depression was increased by 30 percent. The findings, published today in JAMA Psychiatry, have important implications for developing new treatments for depression. Read more..

Rotavirus Vaccine Reduces Severe Diarrhea by 64 Percent

January 29, 2015 9:12 am | by University of Liverpool | News | Comments

Researchers have found that diarrhoea caused by rotavirus infection is significantly reduced in the developing world with the use of a vaccine to prevent the condition. Read more...             

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

January 23, 2015 3:47 pm | News | Comments

The drug gained this designation in Europe. Read more...                                  

Step Closer to Predicting Cancer Patients' Drug Toxicity

January 23, 2015 8:59 am | by University of Adelaide | News | Comments

Being able to predict that a patient will adversely react to a drug that's meant to be treating them is a key aim of personalized medicine, and could help to improve the patient's overall treatment. Read more...                  

Blood Vessels in Older Brains Break Down, Possibly Leading to Alzheimer's

January 22, 2015 11:27 am | by niversity of Southern California | News | Comments

University of Southern California (USC) neuroscientists may have unlocked another puzzle to preventing risks that can lead to Alzheimer's disease.                                                                 

Advertisement

Richter, Actavis Announce Phase 3 Results for Schizophrenia Drug Study

January 20, 2015 9:55 am | News | Comments

Gedeon Richter and Actavis announced positive results from a Phase 3 trial evaluating the efficacy and safety of cariprazine. Read more...                    

Roche Adds Neuromuscular Disease Research to Portfolio

January 20, 2015 9:18 am | News | Comments

Trophos was working on a drug that could treat spinal muscular atrophy. Read more...                              

MRIGlobal Wins $54 Million NIH Neurological Disorders And Stroke Contract

January 16, 2015 11:25 am | News | Comments

MRIGlobal announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials. Read more...

Study Reveals Lack of Data on Opioid Drugs

January 14, 2015 9:35 am | by University of Connecticut | News | Comments

Many of the studies used to justify the prescription of these drugs were either poorly conducted or of an insufficient duration. Read more...                    

Roche, Meiji and Fedora Team Up to Tackle Bacterial Resistance to Antibiotics

January 14, 2015 9:22 am | News | Comments

The three pharmaceutical companies entered into a license agreement for the development and commercialization of a new inhibitor. Read more...                    

Breakthrough on Chronic Pain

January 13, 2015 12:14 pm | by Harvard University | News | Comments

For the first time, scientists have found evidence of neuroinflammation in key regions of the brains of patients with chronic pain, according to a new study from Massachusetts General Hospital (MGH), a Harvard affiliate. Read more...                      

In the News: Open Access Journals

January 13, 2015 8:55 am | by Drug Discovery & Development Staff | Articles | Comments

A number of open access journals have made the news recently. The preprint open access archive, arXiv.org, run by Cornell University, is often used by scientists, from physicists to quantitative biologists, to get their ideas out there quickly and stake out their intellectual ground, before they enter the slow process of peer review. Read more...

Celator Announces Promising Phase 2 Data for AML Drug

January 12, 2015 12:58 pm | News | Comments

Celator Pharmaceuticals published this data earlier today. Read more...                                

Adopting Adaptive Designs: Update

January 12, 2015 8:59 am | by Phil Birch, DPhil, VP Innovation Strategy, Alliance Partnerships at ICON plc. | Articles | Comments

In early 2013, adaptive clinical trials represented 20% of all clinical trials, according to the Tufts CSDD seminal report, The Adoption and Impact of Adaptive Trial DesignsThough that number was expected to grow, lack of education and industry conservatism were named as some of the greatest barriers to widespread adoption of adaptive designs. Read more...

Daiichi Sankyo's AFib Tablets Gain FDA Approval

January 9, 2015 9:36 am | News | Comments

The tablets reduce the risk of stroke and systemic embolism. Read more...                               

Clinical Trial Starts at Ebola Center for Antiviral Drugs

January 7, 2015 9:06 am | by Jonathan Paye-Layleh - Associated Press | News | Comments

A clinical drug trial is now under way at a major health center in Liberia's capital to determine if a medication already used to treat other viruses could help those suffering from Ebola. Read more...          

Nestlé Health Science Invests $65M in Microbiome Therapy Startup

January 6, 2015 12:22 pm | News | Comments

Nestlé Health Science’s investment will help fund the next stage of development of the startup's CDI treatment. Read more...                       

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading